Finland offers BIRD FLU vaccine to humans, but many experts warn against it

07/03/2024 / By Ava Grace

Finland has sparked a heated debate about vaccine safety and necessity after announcing that it will offer bird flu vaccine to humans – the first country to do so.

The Finnish Institute for Health and Welfare (THL) announced plans to begin administering H5N8 bird flu vaccines to select individuals despite the absence of human infection in the country. The unprecedented move comes as global health experts express conflicting views on the threat posed by bird flu. While Finnish officials cite the need for preemptive protection, critics argue the vaccination program is premature and potentially dangerous.

The Finnish announcement comes just two weeks after the European Commission’s Health Emergency Preparedness and Response (HERA) program announced the purchase of 665,000 doses of CSL Seqirus’ H5N8 avian influenza vaccine, with an option to acquire another 40 million doses over the next four years. HERA has already obtained 111 million doses of GSK’s bird flu vaccine.

Helsinki plans to offer the CSL Seqirus H5N8 bird flu vaccine to approximately 10,000 people deemed at high risk of exposure to the virus. Mia Kontio, a health security official at THL, told STAT News that the country was awaiting the arrival of 20,000 doses, with plans to administer them “as soon as the vaccines are in the country.” (Related: Finland to provide bird flu vaccinations to all workers exposed to animals.)

The H5N1 strain of bird flu has caused widespread concern among health authorities in recent years, leading to the culling of hundreds of millions of poultry globally, according to Reuters.

Globally, human infections remain rare. Since December 2021, only eight cases of bird flu have been reported in humans worldwide, according to the World Health Organization.

Experts: Injecting bird flu vaccines to humans is a BAD IDEA

Dr. Peter McCullough argued that even if the bird flu crossed to humans, it would be less dangerous. He added that the alarming statistics on human mortality rates are from long-ago cases in Southeast Asia and that such concerns are “not appropriate” for today’s strains. “Increased transmissibility of H5N1 has a tradeoff of decreased virulence,” he wrote on Substack.

McCullough warned that mass vaccination could lead to a “highly prevalent pandemic” because it “promotes resistant strains of the virus in the vaccinated.” He suggested alternative strategies, including “dilute iodine nasal sprays and gargles, oseltamivir, hydroxychloroquine and other antivirals” for prevention and early treatment.

Internist and bioweapons expert Dr. Meryl Nass pointed out that the product information for the H5N8 bird flu vaccine includes no clinical data for this specific vaccine strain. Meaning, it has not been tested in humans.

Nass noted that scientists don’t have a clear way to measure if the vaccine protects against H5 types of bird flu and that it’s unclear whether the vaccine would work against other similar strains of the virus. She called the product “a dangerous vaccine for a disease that does not exist.”

Jessica Rose, a vaccine analyst and biomathematics specialist, said she has many reservations about the vaccine. “There’s no need for this vaccine, and it poses dangers including tolerization and autoimmune reactions from molecular mimicry,” she told the Defender.

Tolerization occurs when the immune system becomes less responsive to a particular antigen over time, potentially reducing the vaccine’s effectiveness. Meanwhile, molecular mimicry refers to similarities between vaccine components and human proteins, which could lead the immune system to mistakenly attack the body’s tissues and potentially trigger autoimmune disorders.

Geert Vanden Bossche, a renowned virologist, voiced similar concerns. He told the Defender: “Any large-scale vax program using whatever vaccine administered during a pandemic or a panzootic transmissible to humans is at risk of causing large-scale antibody-dependent enhancement of disease and large-scale immune escape.”

Antibody-dependent enhancement is a phenomenon where antibodies produced by the immune system in response to a vaccine or previous infection can worsen a subsequent infection. Instead of protecting against the virus, these antibodies can help the virus enter cells more easily, potentially leading to more severe illness.

Visit Vaccines.news for similar stories.

Watch as Dr. Jane Ruby discusses bird flu, the new plandemic.

This video is from MyPodcastDropped2320 channel on Brighteon.com.